Potential of a deep eutectic solvent in silver nanoparticle fabrication for antibiotic residue detection

• Le Hong Tho,
• Bui Xuan Khuyen,
• Ngoc Xuan Dat Mai and
• Nhu Hoa Thi Tran

Beilstein J. Nanotechnol. 2024, 15, 426–434, doi:10.3762/bjnano.15.38

• [2], the ability of real-time measurements [3], extremely high sensitivity [4], remarkable selectivity [5], and tremendous versatility [4][6][7]. Many scholars have taken advantage of these properties in cancer diagnosis [8], detection of hazardous chemicals [9], tracing of microorganisms [7][10][11

Vinorelbine-loaded multifunctional magnetic nanoparticles as anticancer drug delivery systems: synthesis, characterization, and in vitro release study

• Zeynep Özcan and
• Afife Binnaz Hazar Yoruç

Beilstein J. Nanotechnol. 2024, 15, 256–269, doi:10.3762/bjnano.15.24

• nanostructures employed, particular emphasis has been placed on iron oxide (Fe3O4) nanoparticles. The biocompatibility and low toxicity of Fe3O4 nanoparticles have garnered significant attention in magnetic drug delivery for cancer diagnosis and treatment, primarily because of their magnetic properties [11][12

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• , drug resistance, and tumor relapse are the leading challenges in cancer diagnosis and treatment. The commonly used methods for the diagnosis of cancer involve identification of cancer-causing features in cells, such as DNA and RNA mutations, impaired expression of proteins, and changes in confirmation

• treatment of invasive and metastatic cancers. Based on these findings, it can be suggested that the ACNPs offer significant advancements in cancer diagnosis and treatment. ACNPs are, therefore, efficacious targeted agents with great theranostic ability, enhancing the overall quality of life in preclinical

Examination of the relationship between viscoelastic properties and the invasion of ovarian cancer cells by atomic force microscopy

• Mengdan Chen,
• Jinshu Zeng,
• Weiwei Ruan,
• Zhenghong Zhang,
• Yuhua Wang,
• Shusen Xie,
• Zhengchao Wang and
• Hongqin Yang

Beilstein J. Nanotechnol. 2020, 11, 568–582, doi:10.3762/bjnano.11.45

• The mechanical properties of cells could serve as an indicator for disease progression and early cancer diagnosis. This study utilized atomic force microscopy (AFM) to measure the viscoelastic properties of ovarian cancer cells and then examined the association with the invasion of ovarian cancer at

Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy

• María Sanromán Iglesias and
• Marek Grzelczak

Beilstein J. Nanotechnol. 2020, 11, 263–284, doi:10.3762/bjnano.11.20

• simple blood test, setting thus a milestone of “liquid biopsy”. Liquid biopsy has the potential to accelerate the early cancer diagnosis by the detection of biomolecules such as cell-fee DNA directly in blood samples. Currently, the development of liquid biopsies is directly linked to the state-of-the

• conventional biopsy. Table 1 summarizes the main benefits of liquid biopsy concerning cancer diagnosis, prediction and prognosis emphasizing that it is a promising tool in monitoring tumor-specific changes during the entire course of the disease. It can be used for the early-stage detection of cancer, the

• -nucleotide polymorphism The list of biomarkers that are present in blood and that exhibit potential for cancer diagnosis experiences continuously grows. These biomarkers include circulating tumor cells (CTCs) [30], circulating membranous structures [31], circulating cell-free nucleic acids (cfDNA) [4

A novel electrochemical nanobiosensor for the ultrasensitive and specific detection of femtomolar-level gastric cancer biomarker miRNA-106a

• Maryam Daneshpour,
• Kobra Omidfar and
• Hossein Ghanbarian

Beilstein J. Nanotechnol. 2016, 7, 2023–2036, doi:10.3762/bjnano.7.193

• biomarkers for early cancer diagnosis and prognosis. So far, different strategies have been developed in this regard, such as quantitative reverse transcription PCR (qRT-PCR) [13], locked nucleic acid-based northern blot [14], microarray [15], or flowcytometry [16]. Although there have been advantages to

• method for sensitive, specific and non-invasive miRNA detections in early cancer diagnosis [8]. Biosensors are commonly defined as devices composed of recognition elements interfaced with a transducer, which finally transform a capture process into a detectable output signal. This signal, which is almost

Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection

• Dinusha N. Udukala,
• Hongwang Wang,
• Sebastian O. Wendel,
• Aruni P. Malalasekera,
• Thilani N. Samarakoon,
• Asanka S. Yapa,
• Gayani Abayaweera,
• Matthew T. Basel,
• Pamela Maynez,
• Raquel Ortega,
• Yubisela Toledo,
• Leonie Bossmann,
• Colette Robinson,
• Katharine E. Janik,
• Olga B. Koper,
• Ping Li,
• Massoud Motamedi,
• Daniel A. Higgins,
• Gary Gadbury,
• Gaohong Zhu,
• Deryl L. Troyer and
• Stefan H. Bossmann

Beilstein J. Nanotechnol. 2016, 7, 364–373, doi:10.3762/bjnano.7.33

• by means of a simple serum test. By monitoring CTS B and L stage 0 detection may be achieved. This initial study, comprised of 46 breast cancer patients and 20 apparently healthy human subjects, demonstrates the feasibility of protease-activity-based liquid biopsies for early cancer diagnosis

Simultaneous cancer control and diagnosis with magnetic nanohybrid materials

• Reza Saadat and
• Franz Renz

Beilstein J. Nanotechnol. 2016, 7, 121–125, doi:10.3762/bjnano.7.14

• complexes in order to use them as a new type of radiopharmaceuticals. Keywords: biocompatible nanoparticles; cancer control; cancer diagnosis; magnetite nanoparticles; positron emission tomography; Introduction In the field of diagnostic investigation of metabolic diseases imaging methods based on

PEGylated versus non-PEGylated magnetic nanoparticles as camptothecin delivery system

• Paula M. Castillo,
• Mario de la Mata,
• Maria F. Casula,
• José A. Sánchez-Alcázar and
• Ana P. Zaderenko

Beilstein J. Nanotechnol. 2014, 5, 1312–1319, doi:10.3762/bjnano.5.144

• promising as delivery systems due to their low toxicity and their ability to be used both in cancer diagnosis and therapy [21][22][23]. SPION can be effectively used as contrast agents for magnetic resonance imaging [24][25], as carriers for chemotherapeutic drugs [26][27][28] and to destroy cancer cells by

Carbon dioxide hydrogenation to aromatic hydrocarbons by using an iron/iron oxide nanocatalyst

• Hongwang Wang,
• Jim Hodgson,
• Tej B. Shrestha,
• Prem S. Thapa,
• David Moore,
• Xiaorong Wu,
• Myles Ikenberry,
• Deryl L. Troyer,
• Donghai Wang,
• Keith L. Hohn and
• Stefan H. Bossmann

Beilstein J. Nanotechnol. 2014, 5, 760–769, doi:10.3762/bjnano.5.88

• been developed [34][35][36][37][38][39][40][41]. The application of such materials in cancer diagnosis and cancer treatment, such as MRI and magnetic hyperthermia are intensively studied [42][43][44]. The use of iron-containing nanomaterials as catalysts for the methanol oxidation reaction [45], and